Ryan Specialty (RYAN) Expected to Announce Earnings on Thursday

Ryan Specialty (NYSE:RYAN - Get Free Report) is expected to issue its quarterly earnings data after the market closes on Thursday, February 20th. Analysts expect the company to announce earnings of $0.47 per share and revenue of $658.80 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.

Ryan Specialty Stock Performance

Shares of Ryan Specialty stock traded up $0.14 during trading hours on Friday, hitting $68.75. 933,210 shares of the company's stock traded hands, compared to its average volume of 955,283. Ryan Specialty has a 12-month low of $44.84 and a 12-month high of $75.97. The stock has a market capitalization of $18.00 billion, a price-to-earnings ratio of 89.29, a PEG ratio of 1.19 and a beta of 0.72. The company has a fifty day simple moving average of $65.53 and a 200-day simple moving average of $67.18. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Analyst Upgrades and Downgrades

RYAN has been the subject of several research analyst reports. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating for the company in a research report on Friday, January 10th. Wells Fargo & Company decreased their price objective on Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating for the company in a report on Tuesday, January 14th. Barclays lifted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. Finally, Morgan Stanley assumed coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty has a consensus rating of "Hold" and a consensus target price of $74.40.

Insiders Place Their Bets

In other news, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the sale, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the sale, the director now owns 45,409 shares of the company's stock, valued at approximately $2,954,309.54. This trade represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 323,506 shares of company stock worth $21,407,851 in the last quarter. 11.10% of the stock is owned by company insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.